BIONIC PANCREAS Trademark

Trademark Overview

On Tuesday, April 18, 2023, a trademark application was filed for BIONIC PANCREAS with the United States Patent and Trademark Office. The USPTO has given the BIONIC PANCREAS trademark a serial number of 97893039. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, July 25, 2025. This trademark is owned by BETA BIONICS, INC.. The BIONIC PANCREAS trademark is filed in the Medical Instrument Products category with the following description:

Devices for monitoring, controlling, raising, and lowering blood glucose for medical purposes
bionic pancreas

General Information

Serial Number97893039
Word MarkBIONIC PANCREAS
Filing DateTuesday, April 18, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, July 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDevices for monitoring, controlling, raising, and lowering blood glucose for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2023
Primary Code010
First Use Anywhere DateMonday, June 8, 2015
First Use In Commerce DateMonday, June 8, 2015

Trademark Owner History

Party NameBETA BIONICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCONCORD, MA 01742

Trademark Events

Event DateEvent Description
Friday, April 21, 2023NEW APPLICATION ENTERED
Tuesday, April 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 16, 2024ASSIGNED TO EXAMINER
Tuesday, January 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2024PETITION TO REVIVE-GRANTED
Tuesday, April 23, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, April 23, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 23, 2024TEAS PETITION TO REVIVE RECEIVED
Sunday, December 1, 2024NON-FINAL ACTION E-MAILED
Sunday, December 1, 2024NON-FINAL ACTION WRITTEN
Sunday, December 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 3, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, March 3, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, June 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2025NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, June 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2025EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, June 26, 2025COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, June 26, 2025EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Related Keywords

pancreas bionic glucose medical purposes blood lowering monitoring controlling raising devices